// App-Quantinova.ai

PO1673 : Using Clustering to Facilitate Gene-Based Rare-Variant Collapsing for a Diverse Cohort of FSGS Patients

Researchers

Presenter

  • Povysil Gundula

Principal Investigators

  • Mitrotti Adele

  • Jin Gina Ying

  • Scolari Francesco

  • Santoro Domenico

  • Gesualdo Loreto

  • Fiaccadori Enrico

  • Milosevic Danko

  • Tasic Velibor

  • Saraga Marijan

  • Zaza Gianluigi

  • Westland Rik

  • Simes e silva Ana cristina

  • Gharavi AliG

  • Armisen Javier

  • Paul DirkS

  • Haefliger Carolina

  • Ghiggeri Gian Marco

  • Goldstein DavidB

  • Sanna-Cherchi Simone

Medical Centers

  • Institute for Genomic Medicine Columbia University Irving Medical Center New York NY US New York New York United States

  • Division of Nephrology Columbia University Irving Medical Center New York NY US New York United States

  • Division of Nephrology Columbia University Irving Medical Center New York NY US New York United States

  • Cattedra di Nefrologia Università di Brescia Seconda Divisione di Nefrologia Azienda Ospedaliera Spedali Civili di Brescia Presidio di Montichiari Brescia Italy Brescia Italy

  • Department of Nephrology University of Messina Messina Italy Messina Italy

  • Section of Nephrology Department of Emergency and Organ Transplantation University of Bari Bari Italy Bari Italy

  • Internal Medicine and Nephrology Dept. Parma University Medical School Parma Italy Parma Italy

  • Department of Pediatric Nephrology Dialysis and Transplantation University Hospital Center Zagreb Zagreb Croatia Zagreb Croatia

  • University Children's Hospital Medical Faculty of Skopje Skopje Macedonia Skopje Macedonia (the former Yugoslav Republic of)

  • Department of Pediatrics, University Hospital of Split, Split, Croatia

  • Renal and Dialysis Unit Department of Medicine School of Medicine University of Verona Verona Italy Verona Italy

  • Faculty of Medicine Federal University of Minas Gerais Minas Gerais Brazil Minas Gerais Brazil

  • Centre for Genomics Research Discovery Sciences BioPharmaceuticals R&D AstraZeneca Cambridge UK Cambridge United Kingdom

  • Division of Nephrology Dialysis Transplantation and Laboratory on Pathophysiology of Uremia Istituto G. Gaslini Genoa Italy Genoa Italy

Locations

  • United States

  • Italy

  • Croatia

  • Brazil

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Focal segmental glomerulosclerosis

Biomarkers

  • Alpha-Actinin 4

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A